No abstract available
MeSH terms
-
Anticholesteremic Agents / adverse effects
-
Anticholesteremic Agents / pharmacology
-
Anticholesteremic Agents / therapeutic use
-
Benzimidazoles / adverse effects
-
Benzimidazoles / pharmacology
-
Benzimidazoles / therapeutic use*
-
Cholesterol, LDL / blood
-
Drug Approval
-
Homozygote
-
Humans
-
Hyperlipoproteinemia Type II / drug therapy*
-
Hyperlipoproteinemia Type II / physiopathology
-
Oligonucleotides / adverse effects
-
Oligonucleotides / pharmacology
-
Oligonucleotides / therapeutic use*
-
United States
-
United States Food and Drug Administration
Substances
-
Anticholesteremic Agents
-
BMS201038
-
Benzimidazoles
-
Cholesterol, LDL
-
Oligonucleotides
-
mipomersen